Factors | Anxiety a | Depression b | Post-pandemic stress c | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Mild n (% d) | Moderate to severe n (%d) | Total n (%d) [95% CI] | P e | Mild n (%d) | Moderate to severe n (%d) | Total n (%d) [95% CI] | P e | Total n (%d) [95% CI] | P e | |
Level of education | ||||||||||
  Junior high school or below | 126(2.0%) | 57(9.9%) | 183(31.9%) [28.2-35.8%] | 0.001 | 125(21.8%) | 74(12.9%) | 199(34.7%) [30.9-38.7%] | 0.002 | 43(7.5%) [5.6-9.9%] | 0.536 |
  Senior high school or technical secondary school | 222(24.8%) | 71(7.9%) | 293(32.7%) [29.7-35.8%] |  | 227(25.3%) | 104(11.6%) | 331(36.9%) [33.8-40.1%] |  | 54(6.0%) [4.6-7.7%] |  |
  College degree or higher | 791(30.1%) | 219(8.3%) | 1010(38.4%) [36.6-40.3%] |  | 797(30.3%) | 296(11.3%) | 1093(41.6%) [39.7-43.5%] |  | 177(6.7%) [5.8-7.7%] |  |
Job status | ||||||||||
  Erratic | 224(27.7%) | 94(11.6%) | 318(39.3%) [36.0-42.7%] | 0.044 | 220(27.2%) | 130(16.1%) | 350(43.3%) [39.9-46.7%] | 0.018 | 62(7.7%) [6.0-9.6%] | 0.214 |
  Steady | 915(27.8%) | 253(7.7%) | 1168(35.5%) [33.9-37.2%] |  | 929(28.2%) | 344(10.5%) | 1273(38.7%) [37.1-40.4%] |  | 212(6.4%) [5.6-7.3%] |  |
History of psychiatric disorders | ||||||||||
  No | 1107(27.6%) | 322(8.0%) | 1429(35.6%) [34.1-37.1%] | < 0.001 | 1124(28.0%) | 440(11.0%) | 1564(38.9%) [37.4-40.5%] | < 0.001 | 258(6.4%) [5.7-7.2%] | < 0.001 |
  Yes | 32(39.0%) | 25(30.5%) | 57(69.5%) [59.0-78.7%] |  | 25(30.5%) | 34(41.5%) | 59(72.0%) [61.6-80.8%] |  | 16(19.5%) [12.1-29.1%] |  |
Sleep disorders | ||||||||||
  No | 824(25.2%) | 228(7.0%) | 1052(32.2%) [30.6-33.8%] | < 0.001 | 847(25.9%) | 293(9.0%) | 1140(34.9%) [33.3-36.6%] | < 0.001 | 166(5.1%) [4.4-5.9%] | < 0.001 |
  Insomnia | 121(43.5%) | 64(23.0%) | 185(66.5%) [60.9-71.9%] |  | 106(38.1%) | 96(34.5%) | 202(72.7%) [67.2-77.6%] |  | 55(19.8%) [15.4-24.8%] |  |
  Snoring | 159(33.1%) | 41(8.5%) | 200(41.7%) [37.3-46.1%] |  | 172(35.8%) | 58(12.1%) | 230(47.9%) [43.5-52.4%] |  | 40(8.3%) [6.1-11.1%] |  |
  Both | 20(40.8%) | 13(26.5%) | 33(67.3%) [53.5-79.2%] |  | 12(24.5%) | 23(46.9%) | 35(71.4%) [57.8-82.6%] |  | 13(26.5%) [15.8-40.0%] |  |
  Others | 15(55.6%) | 1(3.7%) | 16(59.3%) [40.6-76.1%] |  | 12(44.4%) | 4(14.8%) | 16(59.3%) [40.6-76.1%] |  | 0(0.0%) - |  |
Sleeping duration/per night | ||||||||||
  < 8 h | 515(31.1%) | 174 (10.5%) | 689(41.7%) [39.3-44.0%] | < 0.001 | 514(31.1%) | 232(14.0%) | 746(45.1%) [42.7-47.5%] | < 0.001 | 133(8.0%) [6.8-9.4%] | < 0.001 |
  ≥ 8 h | 561(26.1%) | 151(7.0%) | 712(33.1%) [31.2-35.1%] |  | 573(26.7%) | 210(9.8%) | 783(36.4%) [34.4-38.5%] |  | 128(6.0%) [5.0-7.0%] |  |
  Variable | 63(21.4%) | 22(7.5%) | 85(28.9%) [24.0-34.3%] |  | 62(21.1%) | 32(10.9%) | 94(32.0%) [26.8-37.5%] |  | 13(4.4%) [2.5-7.2%] |  |
Ongoing treatment | ||||||||||
  None | 614(25.5%) | 203(8.4%) | 817(34.0%) [32.1-35.9%] | < 0.001 | 632(26.3%) | 264(11.0%) | 896(37.3%) [35.3-39.2%] | < 0.001 | 149(6.2%) [5.3-7.2%] | < 0.001 |
  Medication | 420(34.0%) | 111,9.0% | 531(42.9%) [40.2-45.7%] |  | 407(32.9%) | 162(13.1%) | 569(46.0%) [43.2-48.8%] |  | 94(7.6%) [6.2-9.2%] |  |
  Surgical treatment | 25(28.7%) | 9(10.3%) | 34(39.1%) [29.3-49.6%] |  | 22(25.3%) | 17(19.5%) | 39(44.8%) [34.7-55.3%] |  | 12(13.8%) [7.8-22.2%] |  |
  Others | 80(21.7%) | 24(6.5%) | 104(28.2%) [23.8-32.9%] |  | 88(23.8%) | 31(8.4%) | 119(32.2%) [27.6-37.1%] |  | 19(7.5%) [4.7-11.2%] |  |
ED symptom | ||||||||||
  None | 376(21.4%) | 89(5.1%) | 465(26.4%) [24.4-28.5%] | < 0.001 | 385(21.9%) | 113(6.4%) | 498(28.3%) [26.2-30.4%] | < 0.001 | 58(3.3%) [2.5-4.2%] | < 0.001 |
  Mild | 416(31.0%) | 112(8.3%) | 528(39.3%) [36.7-41.9%] |  | 437(32.5%) | 152(11.3%) | 589(43.9%) [41.2-46.5%] |  | 84(6.3%) [5.1-7.6%] |  |
  Moderate to severe | 347(34.9%) | 146(14.7%) | 493(49.6%) [46.5-52.7%] |  | 327(32.9%) | 209(21.0%) | 536(53.9%) [50.8-57.0%] |  | 132(13.3%) [11.3-15.5%] |  |
PE symptom | ||||||||||
  None | 804(26.3%) | 187(6.1%) | 991(32.5%) [30.8-34.1%] | < 0.001 | 818(26.8%) | 256(8.4%) | 1074(35.2%) [33.5-36.9%] | < 0.001 | 140(4.6%) [3.9-5.4%] | < 0.001 |
  Suspected | 138(31.9%) | 44(10.2%) | 182(42.1%) [37.5-46.8%] |  | 132(30.6%) | 61(14.1%) | 193(44.7%) [40.0-49.4%] |  | 42(9.7%) [7.2-12.8%] |  |
  Yes | 197(32.1%) | 116(18.9%) | 313(51.1%) [47.1-55.0%] |  | 199(32.5%) | 157(25.6%) | 356(58.1%) [54.1-61.9%] |  | 92(15.0%) [12.3-18.0%] |  |
Did you get fever, fatigue or headache during pandemic? | ||||||||||
  No | 1114(27.6%) | 338(8.4%) | 1452(36.0%) [34.5-37.5%] | 0.005 | 1116(27.7%) | 462(11.5%) | 1578(39.1%) [37.6-40.6%] | < 0.001 | 265(6.6%) [5.8-7.4%] | 0.017 |
  Yes | 25(39.1%) | 9(14.1%) | 34(53.1%) [41.0-65.0%] |  | 33(51.6%) | 12(18.8%) | 45(70.3%) [58.4-80.4%] |  | 9(14.1%) [7.2-24.1%] |  |
Are you a frontline worker? | ||||||||||
  No | 979(27.2%) | 295(8.2%) | 1274(35.4%) [33.9-37.0%] | 0.004 | 962(26.8%) | 416(11.6%) | 1378(38.3%) [36.8-39.9%] | < 0.001 | 238(6.6%) [5.8-7.5%] | 0.661 |
  Yes | 160(31.7%) | 52(10.3%) | 212(42.1%) [37.8-46.4%] |  | 187(37.1%) | 58(11.5%) | 245(48.6%) [44.3-53.0%] |  | 36(7.1%) [5.1-9.6%] |  |
Have you ever experienced quarantine? | ||||||||||
  No | 879(26.6%) | 269(8.1%) | 1148(34.7%) [33.1-36.4%] | < 0.001 | 873(26.4%) | 365(11.0%) | 1238(37.5%) [35.8-39.1%] | < 0.001 | 216(6.5%) [5.7-7.4%] | 0.051 |
  Centralized | 19(30.2%) | 8(12.7%) | 27(42.9%) [31.2-55.2%] |  | 22(34.9%) | 11(17.5%) | 33(52.4%) [40.2-64.4%] |  | 9(14.3%) [7.3-24.4%] |  |
  Home | 241(33.0%) | 70(9.6%) | 311(42.6%) [39.1-46.2%] |  | 254(34.8%) | 98(13.4%) | 352(48.2%) [44.6-51.8%] |  | 49(6.7%) [5.1-8.7%] |  |
How was your work affected by the pandemic? | ||||||||||
  None | 290(20.8%) | 70(5.0%) | 360(25.8%) [23.6-28.2%] | < 0.001 | 294(21.1%) | 94(6.7%) | 388(27.9%) [25.5-30.3%] | < 0.001 | 47(3.4%) [2.5-4.4%] | < 0.001 |
  Delayed | 250(29.7%) | 77(9.1%) | 327(38.8%) [35.6-42.2%] |  | 252(29.9%) | 115(13.7%) | 367(43.6%) [40.3-47.0%] |  | 62(7.4%) [5.7-9.3%] |  |
  Kept jobless | 29(19.6%) | 25(16.9%) | 54(36.5%) [29.1-44.4%] |  | 26(17.6%) | 33(22.3%) | 59(39.9%) [32.2-47.9%] |  | 18(12.2%) [7.6-18.1%] |  |
  Salary cut or job loss | 471(32.8%) | 153(10.6%) | 624(43.4%) [40.8-46.0%] |  | 476(33.1%) | 202(14.0%) | 678(47.1%) [44.6-49.7%] |  | 122(8.5%) [7.1-10.0%] |  |
  Workload increased | 99(35.7%) | 22(7.9%) | 121(43.7%) [37.9-49.6%] |  | 101(36.5%) | 30(10.8%) | 131(47.3%) [41.5-53.2%] |  | 25(9.0%) [6.1-12.8%] |  |
Are you worried about you and your relatives infected by coronavirus? | ||||||||||
  No | 643(24.6%) | 189(7.2%) | 832(31.8%) [30.0-33.6%] | < 0.001 | 655(25.0%) | 251(9.6%) | 906(34.6%) [32.8-36.4%] | < 0.001 | 127(4.9%) [4.1-5.7%] | < 0.001 |
  Yes | 496(33.5%) | 158(10.7%) | 654(44.2%) [41.7-46.7%] |  | 494(33.4%) | 223(15.1%) | 717(48.4%) [45.9-51.0%] |  | 147(9.9%) [8.5-11.5%] |  |
Are you concerned that infection with coronavirus may affect your sexual function? | ||||||||||
  No | 844(26.0%) | 221(6.8%) | 1065(32.8%) [31.2-34.4%] | < 0.001 | 868(26.7%) | 301(9.3%) | 1169(36.0%) [34.4-37.7%] | < 0.001 | 140(4.3%) [3.7-5.1%] | < 0.001 |
  Yes | 295(34.7%) | 126(14.8%) | 421(49.5%) [46.1-52.8%] |  | 281(33.0%) | 173(20.3%) | 454(53.3%) [50.0-56.7%] |  | 134(15.7%) [13.4-18.3%] |  |
Have you considered choosing cryopreservation of sperm in response to the COVID-19 pandemic? | ||||||||||
  No | 980(27.2%) | 288(8.0%) | 1268(35.2%) [33.6-36.7%] | < 0.001 | 1009(28.0%) | 395(11.0%) | 1404(38.9%) [37.3-40.5%] | 0.016 | 209(5.8%) [5.1-6.6%] | < 0.001 |
  Yes | 159(32.4%) | 59(12.0%) | 218(44.4%) [40.0-48.8%] |  | 140(28.5%) | 79(16.1%) | 219(44.6%) [40.2-49.0%] |  | 65(13.2%) [10.5-16.4%] |  |